Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis-Reference-Cited by-同舟云学术

Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis

Published:2022-10-11 Issue:1 Volume:78 Page:319-321
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Okada Naoko¹²^ORCID,Yazu Hiroyuki²³,Shimizu Eisuke³,Fukagawa Kazumi³,Nunomura Satoshi⁴^ORCID,Saito Hirohisa⁵,Matsumoto Kenji⁵^ORCID,Kawaguchi Atsushi⁶,Izuhara Kenji⁴^ORCID,Fujishima Hiroshi²³

Affiliation:

1. Department of Pharmaceutical Sciences Nihon Pharmaceutical University Saitama Japan

2. Department of Ophthalmology Tsurumi University School of Dental Medicine Yokohama Japan

3. Keio Allergy Center Keio University School of Medicine Tokyo Japan

4. Division of Medical Biochemistry, Department of Biomolecular Sciences Saga Medical School Saga Japan

5. Department of Allergy and Clinical Immunology National Research Institute for Child Health and Development Laboratory Tokyo Japan

6. Education and Research Center for Community Medicine, Faculty of Medicine Saga University Saga Japan

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15535

Reference6 articles.

1. Allergy and the eye

2. Atopic keratoconjunctivitis

3. Japanese guidelines for allergic conjunctival diseases 2020

4. Steroid-induced ocular hypertension in the pediatric age group

5. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis;The Ocular Surface;2024-10

2. Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis;Current Opinion in Allergy & Clinical Immunology;2023-06-06